Napabucasin plus nab-paclitaxel with gemcitabine versus nab-paclitaxel with gemcitabine in previously untreated metastatic pancreatic adenocarcinoma: an adaptive multicentre, randomised, open-label, phase 3, superiority trial

Autor: Bekaii-Saab, Tanios, Okusaka, Takuji, Goldstein, David, Oh, Do-Youn, Ueno, Makoto, Ioka, Tatsuya, Fang, Weijia, Anderson, Eric C., Noel, Marcus S., Reni, Michele, Choi, Hye Jin, Goldberg, Jonathan S., Oh, Sang Cheul, Li, Chung-Pin, Tabernero, Josep, Li, Jian, Foos, Emma, Oh, Cindy, Van Cutsem, Eric
Zdroj: In eClinicalMedicine April 2023 58
Databáze: ScienceDirect